MED17.11 - Mouse DRG Cell Line with Properties of Nociceptors
MED17.11 cells have the potential to replace or reduce the use of primary DRG culture.
SARS-CoV-2 Nucleocapsid Protein (203/204: RG>KR mutant, His-tagged)
A purified, soluble, recombinant SARS-CoV-2 nucleocapsid protein, His-tagged
SARS-CoV-2 Nucleocapsid Protein (His-tagged)
A purified, soluble recombinant SARS-CoV-2 nucleocapsid protein, His-tagged
SARS-CoV-2 Nucleocapsid Protein (Native/Non-tagged)
A purified, soluble recombinant SARS-CoV-2 nucleocapsid protein
Sheffield De-differentiated Liposarcoma Cell Line 01
Cell line derived from a primary De-differentiated Liposarcoma
Sheffield De-differentiated Liposarcoma Cell Line 02
Cell line derived from a primary De-differentiated Liposarcoma resected following neoadjuvant radiotherapy.
Sheffield Leiomyosarcoma Cell Line 01 (w1 variant)
One of two morphologically distinct variant cell lines derived from a primary Leiomyosarcoma
Sheffield Leiomyosarcoma Cell Line 01 (ws variant)
One of two morphologically distinct variant cell lines derived from a primary Leiomyosarcoma
Sheffield Myxofibrosarcoma Cell Line 01 (w1 variant) (Shef-MFS 01 (w1 variant))
Cell line derived from a primary Myxofibrosarcoma
Sheffield Myxofibrosarcoma Cell Line 01 (w2 variant) (Shef-MFS 01 (w2 variant))
Cell line derived from a primary Myxofibrosarcoma
Sheffield Undifferentiated Pleomorphic Sarcoma Cell Line 01
Cell line derived from a primary Undifferentiated Pleomorphic Sarcoma
Sheffield Undifferentiated Pleomorphic Sarcoma Cell Line 02
Cell line derived from a primary Undifferentiated Pleomorphic Sarcoma
Sheffield Undifferentiated Pleomorphic Sarcoma Cell Line 03
Cell line derived from a primary Undifferentiated Pleomorphic Sarcoma
Sheffield Undifferentiated Pleomorphic Sarcoma Cell Line 04
Cell line derived from a primary Undifferentiated Pleomorphic Sarcoma
Tg(mpx:gfp) Transgenic zebrafish model of inflammation
Transgenic zebrafish model of inflammation